International edition
June 15, 2021

TransAct will begin to market it to every jurisdiction in the world

GLI completes testing of Transact Technologies' Epicentral Print System

(US).- TransAct Technologies announced that it recently received a letter from Gaming Laboratories International (GLI) stating that the functional evaluation was completed on its new Epicentral Print System and that GLI determined that it would have no adverse impact on revenue or system integrity, as well as not having any regulatory concerns.

We are excited that GLI has performed their functional evaluation and said we will need no further approval from them,” said Bart C. Shuldman, Chairman and Chief Executive Officer of TransAct Technologies.


“With the successful notification received from GLI, TransAct will begin to market the system to every jurisdiction in the world. Along with the recent expansion of our trial run of the System at Foxwoods, 2011 promises to be a significant year for the Epicentral Print System and we look forward to presenting and selling the System across the globe,” Shuldman added.


The new Epicentral Print System – connected directly to TransAct’s ServerPort device inside the slot machine – is an easy-to-use software system that enables casinos to internally develop marketing programs and promotional coupons to be distributed to customers on a real-time basis at a slot machine.


Additionally, the system works with all existing slot systems and games as it is separate and distinct from the slot system itself. With this, a casino is able to use the Epicentral Print System to connect to any existing slot machine, regardless of the game’s manufacturer or the current slot system, as long as the slot machine is equipped with a TransAct Epic 950 printer.


What is your opinion about this article?
  • I like it
    0 votos
  • I don't like it
    0 votos
  • I have not thought about it
    0 votos
Leave your comment
Newsletter Subscription
Subscribe to receive the latest news and updates
Enter a valid email
Complete the captcha
Thank you for registering to our newsletter.
Follow us on Facebook